Biofrontera Income Statement (2020-2025) | BFRI

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 3.25M39.72M4.74M5.86M4.33M9.17M9.75M4.46M4.32M10.14M8.73M5.85M8.90M10.60M7.91M7.84M9.01M12.56M8.59M9.03M6.99M
Cost of Revenue 0.45M0.16M0.14M0.04M0.18M0.17M0.15M0.10M17.48M4.60M10.40M5.10M-1.36M4.12M4.34M4.88M5.27M3.27M2.64M2.04M
Gross Profit 2.81M4.58M5.72M4.29M8.99M9.58M4.30M4.22M-7.33M4.13M-4.55M3.80M11.95M3.80M3.50M4.13M7.29M5.32M6.39M4.94M
Operating items
Research & Development 0.03M0.03M0.02M0.62M0.67M0.78M1.21M0.87M0.85M
Selling, General & Administrative 4.19M4.76M5.55M17.09M9.10M7.62M9.67M7.76M10.09M9.80M11.46M8.62M-11.38M9.25M7.92M8.43M-9.31M8.65M10.53M10.05M
Restructuring Costs 0.28M0.19M0.20M0.10M
Other Operating Expenses 1.41M3.23M3.80M3.15M1.85M5.25M1.00M0.20M5.68M4.42M3.09M4.86M25.81M4.11M4.37M4.88M22.80M3.27M2.71M2.37M
Operating Expenses 5.60M8.27M9.54M20.44M11.05M12.86M10.67M7.96M15.76M14.22M14.55M13.52M14.46M13.38M12.91M13.97M14.27M13.13M14.11M13.27M
Operating Income -2.34M-3.53M-3.69M-16.11M-1.88M-3.11M-6.21M-3.64M-5.58M-5.49M-8.70M-4.62M-3.87M-5.47M-5.07M-4.96M-1.71M-4.55M-5.08M-6.28M
EBIT -2.34M-3.53M-3.69M-16.11M-1.88M-3.11M-6.21M-3.64M-5.58M-5.49M-8.70M-4.62M-3.87M-5.47M-5.07M-4.96M-1.71M-4.55M-5.08M-6.28M
Non-operating items
Non Operating Investment Income 1.75M-2.94M-1.48M-2.21M-0.79M0.00M-0.01M-0.00M-0.00M0.00M
Interest & Investment Income 0.06M0.04M-0.14M-0.21M-1.41M-0.60M0.01M-0.04M-0.11M-0.12M-0.11M
Other Non Operating Income 0.16M0.08M0.15M0.18M0.27M0.02M0.03M-0.02M0.00M-0.03M0.06M0.04M-0.14M-0.32M0.01M-0.03M-0.10M-0.26M0.03M
Non Operating Income -0.58M0.08M0.07M0.18M-12.88M8.70M5.36M1.07M2.84M-1.98M-1.12M-1.72M7.38M-4.97M4.83M-0.71M0.31M0.34M-0.26M-0.36M
Net income details
EBT -2.92M-3.53M-3.62M-16.01M-14.50M5.59M-0.85M-2.56M-2.78M-7.47M-9.82M-6.34M3.52M-10.44M-0.24M-5.67M-1.40M-4.20M-5.30M-6.64M
Tax Provisions 0.06M0.00M0.04M0.01M0.01M0.03M0.00M0.00M0.01M0.01M0.00M-0.01M0.00M0.02M0.00M-0.00M-0.00M0.02M0.01M
Profit After Tax -2.98M-3.53M-3.66M-16.01M-14.51M5.56M-0.85M-2.57M-2.79M-7.48M-9.84M-6.34M3.53M-10.44M-0.26M-5.67M-1.40M-4.20M-5.32M-6.65M
Income from Continuing Operations -2.98M-3.53M-3.66M-16.01M-14.51M5.56M-0.85M-2.57M-2.79M-7.48M-9.84M-6.34M3.53M-10.44M-0.26M-5.67M-1.40M-4.20M-5.32M-6.65M
Consolidated Net Income -2.98M-3.53M-3.66M-16.01M-14.51M5.56M-0.85M-2.57M-2.79M-7.48M-9.84M-6.34M3.53M-10.44M-0.26M-5.67M-1.40M-4.20M-5.32M-6.65M
Income towards Parent Company -2.98M-3.53M-3.66M-16.01M-14.51M5.56M-0.85M-2.57M-2.79M-7.48M-9.84M-6.34M3.53M-10.44M-0.26M-5.67M-1.40M-4.20M-5.32M-6.65M
Net Income towards Common Stockholders -2.98M-3.53M-3.66M-16.01M-14.51M5.56M-0.85M-2.57M-2.79M-7.48M-9.84M-6.34M3.53M-10.44M-0.26M-5.67M-1.40M-4.20M-5.32M-6.65M
Additional items
EPS (Basic) -0.00M0.01M-0.44-0.46-2.00-1.380.33-0.90-2.26-2.80-0.28-7.23-4.644.55-2.88-0.05-0.980.17-0.47-0.57-0.62
EPS (Weighted Average and Diluted) -0.44-0.46-2.000.32-0.90-2.26-2.80-0.28-7.23-4.644.55-2.88-0.05-0.980.17-0.47-0.57-0.62
Shares Outstanding (Weighted Average) 0.55M0.75M0.75M0.75M0.86M1.18M1.33M1.33M1.33M1.37M1.52M5.09M5.09M5.54M7.75M8.87M9.45M10.67M
Shares Outstanding (Diluted Average) 8.00M8.00M8.00M17.13M0.94M1.14M1.06M1.33M1.36M1.37M1.55M3.62M5.09M5.77M5.52M8.87M9.35M10.78M
EBITDA -2.34M-3.53M-3.69M-16.11M-1.88M-3.11M-6.21M-3.64M-5.58M-5.49M-8.70M-4.62M-3.87M-5.47M-5.07M-4.96M-1.71M-4.55M-5.08M-6.28M
Interest Expenses 0.04M0.14M1.42M0.01M0.62M0.12M
Tax Rate 0.54%0.21%0.02%